Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2010 1
2013 1
2014 1
2015 1
2017 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year

Filters applied: . Clear all
Page 1
Communicating for the Safe Use of Medicines: Progress and Directions for the 2020s Promoted by the Special Interest Group of the International Society of Pharmacovigilance.
Bahri P, Bowring G, Edwards BD, Anton C, Aronson JK, Caro-Rojas A, Hugman BPJ, Mol PG, Trifirò G, Ilic K, Daghfous R, Fermont I, Furlan G, Gaissmaier W, Geer MI, Hartigan-Go KY, Houÿez F, Neth H, Norgela G, Oppamayun Y, Raynor DKT, Bouhlel M, Santoro F, Sultana J. Bahri P, et al. Among authors: edwards bd. Drug Saf. 2023 Jun;46(6):517-532. doi: 10.1007/s40264-023-01285-5. Epub 2023 May 23. Drug Saf. 2023. PMID: 37219785 Free PMC article. Review. No abstract available.
Teaching pharmacovigilance: the WHO-ISoP core elements of a comprehensive modular curriculum.
Beckmann J, Hagemann U, Bahri P, Bate A, Boyd IW, Dal Pan GJ, Edwards BD, Edwards IR, Hartigan-Go K, Lindquist M, McEwen J, Moride Y, Olsson S, Pal SN, Soulaymani-Bencheikh R, Tuccori M, Vaca CP, Wong IC. Beckmann J, et al. Among authors: edwards bd. Drug Saf. 2014 Oct;37(10):743-59. doi: 10.1007/s40264-014-0216-1. Drug Saf. 2014. PMID: 25171836 No abstract available.
A call to incorporate systems theory and human factors into the existing investigation of harm in clinical research involving healthcare products.
Edwards BD, Bégaud B, Daemen E, Dokas I, Fishbein JM, Greenberg HE, Hochberg A, Le Louet H, Lyngvig J, Mogles N, Owen K, Prendergast C, Rejzek M, Trantza S, Webb DJ, Whalen M, Whiteley S. Edwards BD, et al. Br J Clin Pharmacol. 2017 Nov;83(11):2339-2342. doi: 10.1111/bcp.13353. Epub 2017 Jul 19. Br J Clin Pharmacol. 2017. PMID: 28681444 Free PMC article.